Huntington's chorea, formerly known as "St. Vitus' dance," is a rare and incurable brain disorder characterized by movement ...

Huntington's disease, formerly known as "St. Vitus' dance," is a rare and incurable brain disorder characterized by movement ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT®-HD2 study demonstrating an established long-term safety profile, tolerability and sustained ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

Stunning success in halting Huntington's disease with gene therapy offers new hope to those with the disorder—and potential ...

Doctors have reported the first successful treatment for Huntington’s disease, describing the breakthrough as a major step ...

Dutch biotech uniQure recently announced that its novel gene therapy, AMT-130 (ifezuntirgene inilparvovec), demonstrated ...

Huntington’s disease, what we call HD ... His first symptoms were the involuntary movements – the chorea – that most people associate with HD. Now, it’s his memory, his thinking. The cognitive decline ...

I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

On 24 September, uniQure announced positive topline results from its pivotal Phase I/II studies (HD-GENE-TRX1, HD-GENE-TRX2) ...

New gene therapy offers hope for Huntington's disease, potentially increasing quality of life significantly. Trial results indicate a 75% reduction in disease progression after three years, showcasing ...